Analysen von James Quigley
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.01.23 | Merck Overweight | Morgan Stanley | |
| 29.04.22 | EVOTEC Overweight | Morgan Stanley | |
| 25.04.22 | Bayer Overweight | Morgan Stanley | |
|
Werbung
|
|||
| 31.03.22 | Sartorius vz. Overweight | Morgan Stanley | |
| 06.12.21 | EVOTEC Overweight | Morgan Stanley | |
| 12.11.21 | MorphoSys Overweight | Morgan Stanley | |
| 14.07.21 | Bayer Overweight | Morgan Stanley | |
| 24.05.21 | MorphoSys overweight | Morgan Stanley | |
| 19.05.21 | Bayer overweight | Morgan Stanley | |
| 23.02.21 | Bayer overweight | Morgan Stanley | |
| 21.10.20 | Bayer overweight | Morgan Stanley | |
| 14.04.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 30.01.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 28.01.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 27.01.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 13.11.19 | Sartorius vz. overweight | JP Morgan Chase & Co. | |